1. Ramasamy I: Recent Advances in physiological calcium homeostasis. Clin Chem Lab Med. 44:237-273, 2006.
2. Deftos LJ: Clinical Essentials of Calcium and Skeletal Metabolism, Professional Communication Inc, First Edition, pp. 1-208, 1998 (Published on-line at Medscape.com).
3. Bruder JM, Guise TA, and Mundy GR: Mineral Metabolism. In: Endocrinology & Metabolism, Fourth Edition, P. Felig and LA Frohman (eds.); Chapter 22, pp. 1079-1159, 2001.
4. Takeda E, Taketani Y, Sawada N, Sato T, Yamamoto H: The regulation and function of phosphate in the human body. Biofactors. 21:345-355, 2004.
5. Drezner MK: Phosphorus Homeostasis and Related Disorders. In: Principles of Bone Biology, Second Edition, JP Bilezikian, LG Raisz, and GA Rodan (eds.); Chapter 22, pp. 321-338, 2002.
6. Baker SB, Worthley LI: The essentials of calcium, magnesium and phosphate metabolism: part I. Physiology. Crit Care Resusc. 4: 301-306, 2002.
7. Reuss L: Basic Mechanisms of Ion Transport. In: The Kidney, Third Edition, DW Seldin and G Giebisch (eds.); Chapter 3, pp. 85-106, 2000.
8. Berger UV, Peng JB, and Hedier MA: The membrane transporter families in mammals. In: The Kindney, Third Edition, DW Seldin and G Giebisch (eds.); Chapter 4, pp. 107-138, 2000.
9. Kostenuik PJ: Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol. 5:618-625, 2005. Epub 2005 Sep 26.
10. Deftos LJ: Hypercalcemia in malignant and inflammatory diseases. Endocrinology and Metabolism Clinics of North America 31:1-18, 2002.
11. Breitwieser GE: Calcium sensing receptors and calcium oscillations: calcium as a first messenger. Curr Top Dev Biol. 73:85-114, 2006.
12. Deftos LJ: Immunoassays for PTH and PTHrP In: The Parathyroids, Second Edition, JP Bilezikian, R Marcus, and A Levine (eds.), Chapter 9, pp. 143-165, 2001.
13. Chattopadhyay N: Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy. Am J Physiol Endocrinol Metab. 290:E761-770, 2006.
14. Knecht TP, Behling CA, Burton DW, Glass CK, Deftos LJ: The humoral hypercalcemia of benignancy. A newly appreciated syndrome. Am J Clin Pathol. 105:487-492, 1996.
15. Deftos LJ and Gagel R: Calcitonin and Medullary Thyroid Carcinoma In: Cecil Textbook of Medicine, Twentieth Second Edition, JB Wyngarden and JC Bennett, Chapter 265, pp. 1406-1409, 2006.
16. Deftos LJ, Weisman MH, Williams GW, et al: Influence of age and sex on plasma calcitonin in human beings. N Engl J Med 302:1351-1353, 1980.
17. Deftos LJ: There’s something fishy and perhaps fowl about the mammalian calcitonin receptor and its ligand. Endocrinology 138:519-520, 1997. Editorial.
18. Udawela M, Hay DL, Setxon PM: The receptor activity modifying protein family of G protein coupled receptor accessory proteins. Semin Cell Dev Biol. 15:299-308, 2004.
19. Young A: Receptor pharmacology. Adv Pharmacol. 52:47-65, 2005.
20. Hendy GN, Hruska KA, Mathew S, Goltzman D: New insights into mineral and skeletal regulation by active forms of vitamin D. Kidney Int. 69:218-223, 2006.
21. Nagpal S, Na S, Rathnachalam R: Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 26:662-687, 2005. Epub 2005 Mar 29.
22. Christakos S, Dhawan P, Shen Q, Peng X, Benn B, Zhong Y: New insights into the mechanisms involved in the pleiotropic actions of 1,25dihyroxyvitamin D3. Ann N Y Acad Sci. 1068:194-203, 2006.
23. Ross FP, Christiano AM: Nothing but skin and bone. J Clin Invest. 116:1140-1149, 2006.